Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.1.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.1.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.1.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.39.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-18259.5US
JN.1.39.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.39.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-15848China
JN.1.58.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.58.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.58.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.18.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.18.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.18.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LF.4.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LF.4.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LF.4.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XDK.1.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XDK.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDK.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.20NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.20NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.20NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LB.1.7.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LB.1.7.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LB.1.7.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.18.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.18.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.18.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.16.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.16.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.16.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LR.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LR.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LR.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KR.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KR.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KR.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LQ.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LQ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LQ.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XDK.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XDK.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDK.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.4.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.4.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.4.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JF.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JF.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JF.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.2.3.19NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.2.3.19NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used